Loading…

Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation

Background Acute renal failure (ARF) after liver transplantation is associated with high mortality and morbidity. Early therapeutic or preventive intervention is hampered by the lack of early effective prognostic factors. Recent studies indicated that serum levels of cystatin C and β2-microglobulin...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2008-07, Vol.121 (14), p.1251-1256
Main Authors: HEI, Zi-qing, LI, Xiao-yun, SHEN, Ning, PANG, Hong-yu, ZHOU, Shao-li, GUAN, Jian-qiang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413
cites cdi_FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413
container_end_page 1256
container_issue 14
container_start_page 1251
container_title Chinese medical journal
container_volume 121
creator HEI, Zi-qing
LI, Xiao-yun
SHEN, Ning
PANG, Hong-yu
ZHOU, Shao-li
GUAN, Jian-qiang
description Background Acute renal failure (ARF) after liver transplantation is associated with high mortality and morbidity. Early therapeutic or preventive intervention is hampered by the lack of early effective prognostic factors. Recent studies indicated that serum levels of cystatin C and β2-microglobulin (β2 MG) as well as urinary β2 MG and N-acetyI-β-D- glucosaminidase (NAG) would increase in patients with early and mild renal impairment. In this study, these factors were detected during the different stages in patients who accepted orthotopic liver transplantation (OLT), and their feasibilities to predict early ARF after OLT were also analyzed. Methods Sixty patients with normal blood urea nitrogen (BUN) and serum creatinine (SCr) who received modified piggyback liver transplantation without veno-venous bypass were prospectively studied. Blood samples were drawn from patients for the determination of serum β2 MG(n=60), SCr (n=60) and serum Cystatin C (n=39) at following 5 intervals: before operation (TO), 20 minutes before anhepatic phase (T1), 25 minutes in anhepatic (T2), 60 minutes after reperfusion (T3) and at the end of operation(T4). Urinary B2 MG (n=60) and NAG (n=60) were also examined at following 3 intervals: before operation (TO), 60 minutes after reperfusion (T3) and at the end of operation (T4). According to the Rimola A criteria of ARF in 24 hours after operation, all the patients were divided into two groups: ARF group and non-ARF group. The data were statistically analyzed to evaluate the feasibiliy of regarding these factors as prognostic factors for early ARF after liver transplantation in patients with normal SCr and BUN before operation. Results Ten of sixty cases showed ARF(16.7%). The Logistic regression analysis showed that the levels of serum and urinary β2 MG as well as serum cystatin C before operation were correlated with early ARF after liver transplantation (P 〈0.05), while only serum levels of cystatin C and Cr at the end of operation correlated with early ARF (P〈0.05, P〈0.01) after liver transplantation. The serum β2 MG, Cystatin C, SCr and urinary β2 MG levels in ARF group were much more higher than that in non-ARF group(P 〈0.05, P 〈0.01). There were significant differences between the correct and false predictive positive ratios of serum cystatin C, serum and urinary β2 MG levels before operation (P 〈0.05, P 〈0.01), while only SCr showed significant difference between these groups at the end of operation (P 〈0.01). Conclusions
doi_str_mv 10.1097/00029330-200807020-00001
format article
fullrecord <record><control><sourceid>crossref_chong</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00029330_200807020_00001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>27776221</cqvip_id><sourcerecordid>10_1097_00029330_200807020_00001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413</originalsourceid><addsrcrecordid>eNplkE1OJDEMhSMEEs3PHaJZE3BSVUlniXoGGAkNLGBdcqecJkw6BUkVUh8LDsKZpvibDRtbst-z_D7GuIRjCdacAICyVQVCAczBgAIxjUBusZlqaiUaXcttNoNKa6Gttbtsr5T7ydQ0Rs_Y83XuV6kvQ3D8CeNIhfeeF8rjmrtNGXAIiS84po6_vii-Dm7Sx345xpCO-JhDwrz5vno3_BHoaNhE8foifopVHF1fcB1S6LAQn0SEOW44unEgnilh5B5DHDNx9ANlHsPTVIeMqTxETG_P9OmA7XiMhQ4_-z67Pft1s7gQl1fnvxenl8KpRkpBjaWuQkONWzbW1bWRzjhjLNTGz6nTGudAdWet9J3x6NBAt3TkSGtjalnts_nH3SlWKZl8-5DDekrbSmjf0Ldf6Nv_6Nt39JP1x6f1rk-rx5BW7RLdXx8itcoYo5WS1T8ijold</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>HEI, Zi-qing ; LI, Xiao-yun ; SHEN, Ning ; PANG, Hong-yu ; ZHOU, Shao-li ; GUAN, Jian-qiang</creator><creatorcontrib>HEI, Zi-qing ; LI, Xiao-yun ; SHEN, Ning ; PANG, Hong-yu ; ZHOU, Shao-li ; GUAN, Jian-qiang</creatorcontrib><description>Background Acute renal failure (ARF) after liver transplantation is associated with high mortality and morbidity. Early therapeutic or preventive intervention is hampered by the lack of early effective prognostic factors. Recent studies indicated that serum levels of cystatin C and β2-microglobulin (β2 MG) as well as urinary β2 MG and N-acetyI-β-D- glucosaminidase (NAG) would increase in patients with early and mild renal impairment. In this study, these factors were detected during the different stages in patients who accepted orthotopic liver transplantation (OLT), and their feasibilities to predict early ARF after OLT were also analyzed. Methods Sixty patients with normal blood urea nitrogen (BUN) and serum creatinine (SCr) who received modified piggyback liver transplantation without veno-venous bypass were prospectively studied. Blood samples were drawn from patients for the determination of serum β2 MG(n=60), SCr (n=60) and serum Cystatin C (n=39) at following 5 intervals: before operation (TO), 20 minutes before anhepatic phase (T1), 25 minutes in anhepatic (T2), 60 minutes after reperfusion (T3) and at the end of operation(T4). Urinary B2 MG (n=60) and NAG (n=60) were also examined at following 3 intervals: before operation (TO), 60 minutes after reperfusion (T3) and at the end of operation (T4). According to the Rimola A criteria of ARF in 24 hours after operation, all the patients were divided into two groups: ARF group and non-ARF group. The data were statistically analyzed to evaluate the feasibiliy of regarding these factors as prognostic factors for early ARF after liver transplantation in patients with normal SCr and BUN before operation. Results Ten of sixty cases showed ARF(16.7%). The Logistic regression analysis showed that the levels of serum and urinary β2 MG as well as serum cystatin C before operation were correlated with early ARF after liver transplantation (P 〈0.05), while only serum levels of cystatin C and Cr at the end of operation correlated with early ARF (P〈0.05, P〈0.01) after liver transplantation. The serum β2 MG, Cystatin C, SCr and urinary β2 MG levels in ARF group were much more higher than that in non-ARF group(P 〈0.05, P 〈0.01). There were significant differences between the correct and false predictive positive ratios of serum cystatin C, serum and urinary β2 MG levels before operation (P 〈0.05, P 〈0.01), while only SCr showed significant difference between these groups at the end of operation (P 〈0.01). Conclusions The results revealed that there was potential renal damage among those patients who demonstrated normal SCr and BUN before operation, and that liver transplantation could aggravate this damage and causing ARF. Here we provided the prognostic values of serum Cystatin C, β2 MG, urinary β2 MG and NAG in patients with early acute renal failure after liver transplantation.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.1097/00029330-200807020-00001</identifier><language>eng</language><subject>β2-微球蛋白 ; 并发症 ; 急性肾衰竭 ; 肝移植</subject><ispartof>Chinese medical journal, 2008-07, Vol.121 (14), p.1251-1256</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413</citedby><cites>FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>HEI, Zi-qing</creatorcontrib><creatorcontrib>LI, Xiao-yun</creatorcontrib><creatorcontrib>SHEN, Ning</creatorcontrib><creatorcontrib>PANG, Hong-yu</creatorcontrib><creatorcontrib>ZHOU, Shao-li</creatorcontrib><creatorcontrib>GUAN, Jian-qiang</creatorcontrib><title>Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background Acute renal failure (ARF) after liver transplantation is associated with high mortality and morbidity. Early therapeutic or preventive intervention is hampered by the lack of early effective prognostic factors. Recent studies indicated that serum levels of cystatin C and β2-microglobulin (β2 MG) as well as urinary β2 MG and N-acetyI-β-D- glucosaminidase (NAG) would increase in patients with early and mild renal impairment. In this study, these factors were detected during the different stages in patients who accepted orthotopic liver transplantation (OLT), and their feasibilities to predict early ARF after OLT were also analyzed. Methods Sixty patients with normal blood urea nitrogen (BUN) and serum creatinine (SCr) who received modified piggyback liver transplantation without veno-venous bypass were prospectively studied. Blood samples were drawn from patients for the determination of serum β2 MG(n=60), SCr (n=60) and serum Cystatin C (n=39) at following 5 intervals: before operation (TO), 20 minutes before anhepatic phase (T1), 25 minutes in anhepatic (T2), 60 minutes after reperfusion (T3) and at the end of operation(T4). Urinary B2 MG (n=60) and NAG (n=60) were also examined at following 3 intervals: before operation (TO), 60 minutes after reperfusion (T3) and at the end of operation (T4). According to the Rimola A criteria of ARF in 24 hours after operation, all the patients were divided into two groups: ARF group and non-ARF group. The data were statistically analyzed to evaluate the feasibiliy of regarding these factors as prognostic factors for early ARF after liver transplantation in patients with normal SCr and BUN before operation. Results Ten of sixty cases showed ARF(16.7%). The Logistic regression analysis showed that the levels of serum and urinary β2 MG as well as serum cystatin C before operation were correlated with early ARF after liver transplantation (P 〈0.05), while only serum levels of cystatin C and Cr at the end of operation correlated with early ARF (P〈0.05, P〈0.01) after liver transplantation. The serum β2 MG, Cystatin C, SCr and urinary β2 MG levels in ARF group were much more higher than that in non-ARF group(P 〈0.05, P 〈0.01). There were significant differences between the correct and false predictive positive ratios of serum cystatin C, serum and urinary β2 MG levels before operation (P 〈0.05, P 〈0.01), while only SCr showed significant difference between these groups at the end of operation (P 〈0.01). Conclusions The results revealed that there was potential renal damage among those patients who demonstrated normal SCr and BUN before operation, and that liver transplantation could aggravate this damage and causing ARF. Here we provided the prognostic values of serum Cystatin C, β2 MG, urinary β2 MG and NAG in patients with early acute renal failure after liver transplantation.</description><subject>β2-微球蛋白</subject><subject>并发症</subject><subject>急性肾衰竭</subject><subject>肝移植</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNplkE1OJDEMhSMEEs3PHaJZE3BSVUlniXoGGAkNLGBdcqecJkw6BUkVUh8LDsKZpvibDRtbst-z_D7GuIRjCdacAICyVQVCAczBgAIxjUBusZlqaiUaXcttNoNKa6Gttbtsr5T7ydQ0Rs_Y83XuV6kvQ3D8CeNIhfeeF8rjmrtNGXAIiS84po6_vii-Dm7Sx345xpCO-JhDwrz5vno3_BHoaNhE8foifopVHF1fcB1S6LAQn0SEOW44unEgnilh5B5DHDNx9ANlHsPTVIeMqTxETG_P9OmA7XiMhQ4_-z67Pft1s7gQl1fnvxenl8KpRkpBjaWuQkONWzbW1bWRzjhjLNTGz6nTGudAdWet9J3x6NBAt3TkSGtjalnts_nH3SlWKZl8-5DDekrbSmjf0Ldf6Nv_6Nt39JP1x6f1rk-rx5BW7RLdXx8itcoYo5WS1T8ijold</recordid><startdate>20080720</startdate><enddate>20080720</enddate><creator>HEI, Zi-qing</creator><creator>LI, Xiao-yun</creator><creator>SHEN, Ning</creator><creator>PANG, Hong-yu</creator><creator>ZHOU, Shao-li</creator><creator>GUAN, Jian-qiang</creator><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080720</creationdate><title>Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation</title><author>HEI, Zi-qing ; LI, Xiao-yun ; SHEN, Ning ; PANG, Hong-yu ; ZHOU, Shao-li ; GUAN, Jian-qiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>β2-微球蛋白</topic><topic>并发症</topic><topic>急性肾衰竭</topic><topic>肝移植</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HEI, Zi-qing</creatorcontrib><creatorcontrib>LI, Xiao-yun</creatorcontrib><creatorcontrib>SHEN, Ning</creatorcontrib><creatorcontrib>PANG, Hong-yu</creatorcontrib><creatorcontrib>ZHOU, Shao-li</creatorcontrib><creatorcontrib>GUAN, Jian-qiang</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>CrossRef</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HEI, Zi-qing</au><au>LI, Xiao-yun</au><au>SHEN, Ning</au><au>PANG, Hong-yu</au><au>ZHOU, Shao-li</au><au>GUAN, Jian-qiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2008-07-20</date><risdate>2008</risdate><volume>121</volume><issue>14</issue><spage>1251</spage><epage>1256</epage><pages>1251-1256</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background Acute renal failure (ARF) after liver transplantation is associated with high mortality and morbidity. Early therapeutic or preventive intervention is hampered by the lack of early effective prognostic factors. Recent studies indicated that serum levels of cystatin C and β2-microglobulin (β2 MG) as well as urinary β2 MG and N-acetyI-β-D- glucosaminidase (NAG) would increase in patients with early and mild renal impairment. In this study, these factors were detected during the different stages in patients who accepted orthotopic liver transplantation (OLT), and their feasibilities to predict early ARF after OLT were also analyzed. Methods Sixty patients with normal blood urea nitrogen (BUN) and serum creatinine (SCr) who received modified piggyback liver transplantation without veno-venous bypass were prospectively studied. Blood samples were drawn from patients for the determination of serum β2 MG(n=60), SCr (n=60) and serum Cystatin C (n=39) at following 5 intervals: before operation (TO), 20 minutes before anhepatic phase (T1), 25 minutes in anhepatic (T2), 60 minutes after reperfusion (T3) and at the end of operation(T4). Urinary B2 MG (n=60) and NAG (n=60) were also examined at following 3 intervals: before operation (TO), 60 minutes after reperfusion (T3) and at the end of operation (T4). According to the Rimola A criteria of ARF in 24 hours after operation, all the patients were divided into two groups: ARF group and non-ARF group. The data were statistically analyzed to evaluate the feasibiliy of regarding these factors as prognostic factors for early ARF after liver transplantation in patients with normal SCr and BUN before operation. Results Ten of sixty cases showed ARF(16.7%). The Logistic regression analysis showed that the levels of serum and urinary β2 MG as well as serum cystatin C before operation were correlated with early ARF after liver transplantation (P 〈0.05), while only serum levels of cystatin C and Cr at the end of operation correlated with early ARF (P〈0.05, P〈0.01) after liver transplantation. The serum β2 MG, Cystatin C, SCr and urinary β2 MG levels in ARF group were much more higher than that in non-ARF group(P 〈0.05, P 〈0.01). There were significant differences between the correct and false predictive positive ratios of serum cystatin C, serum and urinary β2 MG levels before operation (P 〈0.05, P 〈0.01), while only SCr showed significant difference between these groups at the end of operation (P 〈0.01). Conclusions The results revealed that there was potential renal damage among those patients who demonstrated normal SCr and BUN before operation, and that liver transplantation could aggravate this damage and causing ARF. Here we provided the prognostic values of serum Cystatin C, β2 MG, urinary β2 MG and NAG in patients with early acute renal failure after liver transplantation.</abstract><doi>10.1097/00029330-200807020-00001</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2008-07, Vol.121 (14), p.1251-1256
issn 0366-6999
2542-5641
language eng
recordid cdi_crossref_primary_10_1097_00029330_200807020_00001
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects β2-微球蛋白
并发症
急性肾衰竭
肝移植
title Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A23%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_chong&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20values%20of%20serum%20cystatin%20C%20and%20%CE%B22%20microglobulin,%20urinary%20%CE%B22%20microglobulin%20and%20N-acetyl-%CE%B2-D-glucosaminidase%20in%20early%20acute%20renal%20failure%20after%20liver%20transplantation&rft.jtitle=Chinese%20medical%20journal&rft.au=HEI,%20Zi-qing&rft.date=2008-07-20&rft.volume=121&rft.issue=14&rft.spage=1251&rft.epage=1256&rft.pages=1251-1256&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.1097/00029330-200807020-00001&rft_dat=%3Ccrossref_chong%3E10_1097_00029330_200807020_00001%3C/crossref_chong%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2511-e59ed3a7e5cb59c4471c7c779047f8ed66a80e4d991fd7faca70dbcece6677413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_cqvip_id=27776221&rfr_iscdi=true